- Pip Munch
- Posts
- π One space stock is up 786% this year
π One space stock is up 786% this year

Watch What Happens After This Ticker Hits #1 (Ad)
Most traders are flying blind β working off data that's 15, 20, even 30 minutes old.
But a small segment of βin the knowβ traders are using a tool inside the Stocks.News appβ and it's quietly handing them an advantage every morning.
Every day before the market heats up, Stocks.News fires up a proprietary scanner that tears through LIVE market data to zero in on the highest-probability breakouts of the day. The result? A ranked Top 5 Stocks list, updated in real time as breakout probability shifts.
And the results have been jaw-dropping. Over the past week, nearly every stock that hit the #1 spot went on to surge 100%+ within days. The most recent #1 pick climbed 119% in under 72 hours.
This isn't luck. This is the right data, at the right time, pointing you in the right direction.
Opt In Disclaimer: By clicking the link above, I agree that Stocks.News and their affiliates may email me, with offers and other info. Additionally, I agree to the following terms of service, disclaimer and privacy policy.

BIG PICTURE
π’ Not Our Usual Beat. But We Couldn't Resist.
This isn't the typical story we cover. But a Miami jury just handed a nurse $300,000 for downing 14 tequila shots in 9 hours on a Carnival cruise ship, blacking out, falling down the stairs, and waking up in a staff-only area. The jury found $CCL 60% at fault for overserving her.
Let that sink in. She out-earned my entire lifetime trading earnings by drinking what any professional cruiser does by noon.
Here's the real kicker. Carnival's market cap sits at roughly $35 billion. That $300,000 verdict is the financial equivalent of finding a loose quarter in a couch the size of a football stadium. They will not notice it. Their accountants will not notice it. A single onboard margarita upsell probably covers it.

The Stock Situation: $CCL has had a rough 2026. The Iran war hammered cruise stocks back in March. Oil costs are elevated, fuel costs are up, and the stock is trading around $27 after hitting a 52-week high of $34. Headwinds are real but improving.
The Munch Take: This woman turned tequila into a legal strategy and walked away with $300,000. Meanwhile I'm sitting here refreshing charts and all Iβm seeing is red. My wife heard this story and immediately started researching cruise deals. I'm choosing not to ask follow-up questions.
5 Space Stocks Set to Watch as the New Space Race Heats Up (Ad)
With NASAβs Artemis missions driving a return to the Moon, space is entering a new growth phase.
Launch costs have fallen dramatically, unlocking a surge in commercial activity and a rise in government spending are fueling demand for satellites, defense systems, and global connectivity.
The new space economy is quickly becoming a long-term infrastructure play βwith contracts and recurring revenue to match.
In this free report, we highlight five publicly traded companies across launch, satellites, defense, and space-based intelligenceβpositioned to benefit as the industry expands.
Inside, youβll discover:
A rocket company expanding beyond launches into spacecraft manufacturing and recurring revenue
The defense contractor that builds some of the most critical satellites in U.S. orbit
A satellite network that works where 5G and fiber canβt reach, serving aviation, maritime and government users
A real-time spy-satellite company selling intelligence to governments and corporations
And a behind-the-scenes defense supplier keeping satellite operations secure and running
To your trading success,
The Buzzing Markets Team
By clicking the link above, you agree to receive future emails from Buzzing Markets Newsletter and bonus subscriptions from our partners. You can opt out at any time. - Privacy Policy
STOCKS OF THE DAY
π RFK Just Handed Hims A Peptide Rocket. Should You Get On Board?
Every podcast health bro has gone from screaming about Ozempic to screaming about peptides. I don't fully understand it. But I do understand a 25% stock move in two days.
Here's what happened. $HIMS ripped after RFK Jr. announced the FDA will remove 12 peptides from Category 2 restrictions. Category 2 is where regulators park drugs they consider too risky to compound. Moving them out opens a massive legal market for telehealth platforms. Hims already owns a peptide manufacturing facility in California. They were positioned before anyone blew the whistle.
π The Bull Case:
Hims owns the infrastructure. The facility is already built.
Peptides are the next GLP-1 wave. The demand is already there.
Regulatory clarity turns a gray market into a legitimate business.
π The Bear Case:
The FDA advisory meeting isn't until July. This is a catalyst preview, not a catalyst.
Insiders have been selling. Aggressively.
P/E sits around 50x on declining net income. That's not cheap.

The Munch Take: Real story. Real upside. But the stock moved first and the revenue comes later β Bank of America says not until 2027. I'm still keeping my shirt on at the in-laws' pool regardless of what RFK Jr. approves. I prefer keeping the Casper jokes to a minimum.
What do you think of today's edition? |
Share Pip Munch
Chances are you have some trading friends. Why donβt you be a pal, share Pip Munch and earn some goodies for it?
You currently have 0 referrals, only 1 away from receiving The Trading Plan That Helped Me Pass 4 $100,000 FTMO Challenges.
Or copy and paste this link to others: https://pipmunch.com/subscribe?ref=PLACEHOLDER
A portion of this message is a sponsored advertisement sent on behalf of Stocks.News. Lark Dashboards receives compensation for this placement. We do not endorse or recommend any specific investments. Please do your own research.
If you have questions or concerns about your subscription, feel free to contact our Canadian-based support team at [email protected].